Canntab Therapeutics Limited
PILL
Rank in Stocks
#40498
Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office... Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office in Markham, Canada, is dedicated to the research and development of sophisticated, medical-grade cannabinoid compounds. The company's diverse portfolio within Canada includes various orally administered pharmaceutical cannabis products. These innovative dosage forms encompass extended-release cannabinoid pellets, rapid-onset cannabidiol options, multi-layered modified-release formulations, quickly dissolving flash-melt versions, and dual-layer cannabinoid tablets. Canntab's products are designed to address a wide spectrum of health concerns, such as sleep disturbances, post-traumatic stress disorder, social anxiety, different forms of addiction, arthritic conditions, general pain management, alleviating pain and stimulating appetite for cancer patients, and aiding in recovery from opioid and other painkiller dependencies.
Share Price
$0.0036163
Last synced: 2023-10-30
Market Cap
$118.21K
Change (1 day)
0.39%
Change (1 year)
3,516.30%
Country
CA
Trade Canntab Therapeutics Limited (PILL)
Category
Healthcare
Stock split history for Canntab Therapeutics Limited (PILL)
Canntab Therapeutics Limited stock (symbol: PILL) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 20, 2026.
One PILL share bought prior to Oct 20, 2026 would equal to 0 PILL shares today.
The most recent stock split occurred on Oct 20, 2026.
One PILL share bought prior to Oct 20, 2026 would equal to 0 PILL shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
